Abstract
Considered the second most common malignancy of the urinary tract, bladder cancer (BC) causes great concern due to the alarming estimates that grow every year. Among the therapies used in the BC, stand out BCG immunotherapy and chemotherapy. However, their efficiency is limited due to some factors such as, for example, the unwanted side effects and the high rate of recurrence after treatm…